Hedge Fund Activism Changes Corporate R&D Investment Time Horizon

It understates the situation to simply state the pace of shareholder activism has increased recently.  What we are witnessing is “activism on steroids,” says a new academic white paper that considers the impact of activist investors on publicly traded stocks.  The study considers the negative impacts on research and development and shortening the corporate investment time horizon.
Impact of shareholder activism on publically traded stocks
While the impact on the stock price in the . . .


This content is exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here

If you are subscribed and having an account error please clear cache and then cookies if that does not work email support@valuewalk.com and we will get back to you as quick as humanly possible

Saved Articles

Are you a smart investor? Join tens of thousands of sophisticated investor reading our authoritative free newsletter

* indicates required

Congrats! Are you a smart person?

We have an exclusive targeted for being a sophisticated and loyal reader.

Sign up today and get three months free

Use coupon code 2019VIP or click on the button below

Limited time offer only ENDS TONIGHT or next 20 5 subscribers whichever comes first – please do not share this discount with others